Evidence map›Paper›PMID 21109307›Full record

ArticleJournal of affective disorders2011

Depression and eating disorders: treatment and course.

David Mischoulon, Kamryn T Eddy, Aparna Keshaviah, Diana Dinescu, Stephanie L Ross, Andrea E Kass, Debra L Franko, David B Herzog

Open access · greenAbstract read
In one paragraph

Article in Journal of affective disorders, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 137 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Anxiety, Obsessive-Compulsive, and Depressive Symptom Presentation and Change Throughout Routine Eating Disorder Treatment.European eating disorders review : the journal of the Eating Disorders Association · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

David MischoulonDepression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, USA. dmischoulon@partners.org
Kamryn T Eddy
Aparna Keshaviah
Diana Dinescu
Stephanie L Ross
Andrea E Kass
Debra L Franko
David B Herzog
Massachusetts General Hospital · USHarvard University · USNortheastern University · US

Funding

LONGITUDINAL STUDY OF ANOREXIA NERVOSA BULIMIC DISEASER01MH038333 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI HERZOG, DAVID B · 1987 to 1999
–
NIMH NIH HHS 5R01 MH 38333 05NIMH NIH HHS R01 MH038333
6 · The paper itself

Abstract

backgroundWe examined the course of major depressive disorder (MDD) and predictors of MDD recovery and relapse in a longitudinal sample of women with eating disorders (ED).

methods246 Boston-area women with DSM-IV anorexia nervosa-restricting (ANR; n=51), AN-binge/purge (ANBP; n=85), and bulimia nervosa (BN; n=110) were recruited between 1987 and 1991 and interviewed using the Eating Disorders Longitudinal Interval Follow-up Evaluation (LIFE-EAT-II) every 6-12 months for up to 12 years. 100 participants had MDD at study intake and 45 developed MDD during the study. Psychological functioning and treatment were assessed.

resultsTimes to MDD onset (1 week-4.3 years), recovery (8 weeks-8.7 years), and relapse (1 week-5.2 years) varied. 70% recovered from MDD, but 65% subsequently relapsed. ANR patients were significantly less likely to recover from MDD than ANBP patients (p=0.029). Better psychological functioning and history of MDD were associated with higher chance of MDD recovery. Higher baseline depressive severity and full recovery from ED were associated with greater likelihood of MDD relapse; increased weight loss was somewhat protective. Adequate antidepressant treatment was given to 72% of patients with MDD and generally continued after MDD recovery. Time on antidepressants did not predict MDD recovery (p=0.27) or relapse (p=0.26). LIMITATIONS: Small ED diagnostic subgroups; lack of non-ED control group.

conclusionsThe course of MDD in EDs is protracted; MDD recovery may depend on ED type. Antidepressants did not impact likelihood of MDD recovery, nor protect against relapse, which may impact on treatment strategies for comorbid MDD and EDs.

Indexed as

AdolescentAdultAnorexia NervosaAntidepressive AgentsBinge-Eating DisorderBostonBulimia NervosaComorbidityDiagnostic and Statistical Manual of Mental DisordersFeeding and Eating DisordersFemaleFollow-Up StudiesHumansMajor Depressive DisorderPrognosisSecondary PreventionAntidepressive Agents

Identifiers

PMID21109307
PMCPMC3085695
OpenAlexW1969422958

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.